{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:49:15Z","timestamp":1785761355850,"version":"3.56.0"},"reference-count":33,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background\/Objectives: Nonselective beta blockers (NSBBs) are widely used in cirrhosis for portal hypertension, but their safety in older adults with decompensated cirrhosis remains uncertain. Methods: We conducted a retrospective multicenter cohort study using the TriNetX Research Network. Adults aged 30\u201390 years with decompensated cirrhosis were stratified into three groups: 30\u201360 years, 61\u201390 years, and a prespecified subgroup of 81\u201390 years. NSBB exposure (propranolol, nadolol, or carvedilol) within 30 days of decompensation was assessed, and 1:1 propensity score matching was performed within each age group. The primary outcome was 12-month all-cause mortality. Secondary outcomes included acute kidney injury (AKI), electrolyte abnormalities, and acute care utilization. Results: After matching, 40,074 pairs (30\u201360 years), 96,084 pairs (61\u201390 years), and 19,024 pairs (81\u201390 years) were analyzed. NSBB use was associated with lower 12-month mortality in ages 30\u201360 (4.0% vs. 4.6%; RR 0.86, 95% confidence interval [CI] 0.81\u20130.92). 61\u201390-year cohort, mortality was similar between groups (7.4% vs. 7.4%; RR 0.99, 95% CI 0.96\u20131.02). Patients aged 81\u201390 years, NSBB use was associated with higher mortality (10.9% vs. 10.0%; RR 1.08, 95% CI 1.02\u20131.16). Across age strata, NSBB was associated with increased AKI, hyperkalemia, and acute care visits. Conclusions: NSBB therapy was associated with reduced mortality in younger adults (30\u201360 years) but not in older patients (61\u201390 years) and was associated with increased mortality among those aged 81\u201390 years. These findings support individualized NSBB use and suggest that patient age should be considered when weighing potential benefits and risks.<\/jats:p>","DOI":"10.3390\/jcm15155998","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:50:21Z","timestamp":1785757821000},"page":"5998","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Age-Stratified Mortality Outcomes Associated with Nonselective Beta-Blocker Use in Patients with Decompensated Cirrhosis"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-5967-7986","authenticated-orcid":false,"given":"Ahmad","family":"Nawaz","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, SUNY Upstate Medical University, Syracuse, NY 13210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3749-2317","authenticated-orcid":false,"given":"Avneet","family":"Kaur","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, SUNY Upstate Medical University, Syracuse, NY 13210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelkader","family":"Chaar","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, SUNY Upstate Medical University, Syracuse, NY 13210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Aswath","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, SUNY Upstate Medical University, Syracuse, NY 13210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idan","family":"Goren","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, SUNY Upstate Medical University, Syracuse, NY 13210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savio","family":"John","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, SUNY Upstate Medical University, Syracuse, NY 13210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver Cirrhosis","volume":"371","author":"Schuppan","year":"2008","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.3748\/wjg.v17.i18.2273","article-title":"Management of liver cirrhosis between primary care and specialists","volume":"17","author":"Grattagliano","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1002\/hep.30494","article-title":"Incidence and Mortality of Acute on Chronic Liver Failure using Two Definitions in Patients with Compensated Cirrhosis","volume":"69","author":"Mahmud","year":"2019","journal-title":"Hepatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"16041","DOI":"10.1038\/nrdp.2016.41","article-title":"Acute-on-chronic liver failure in cirrhosis","volume":"2","author":"Arroyo","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.24418","article-title":"Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis","volume":"54","author":"Berzigotti","year":"2011","journal-title":"Hepatology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jhep.2021.01.002","article-title":"Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction","volume":"75","author":"Engelmann","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1080\/00365521.2018.1506046","article-title":"Evaluation of portal hypertension in the cirrhotic patient: Hepatic vein pressure gradient and beyond","volume":"53","author":"Karagiannakis","year":"2018","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0168-8278(85)80770-4","article-title":"Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators","volume":"1","author":"Bhathal","year":"1985","journal-title":"J. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1586\/egh.12.83","article-title":"Assessing portal hypertension in liver diseases","volume":"7","author":"Berzigotti","year":"2013","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1053\/j.gastro.2018.01.028","article-title":"Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients with Cirrhosis","volume":"154","author":"Roccarina","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"s60","DOI":"10.7861\/clinmedicine.18-2-s60","article-title":"Management of decompensated cirrhosis","volume":"18","author":"Mansour","year":"2018","journal-title":"Clin. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cld.2021.01.004","article-title":"Prevention of Variceal Bleeding and Rebleeding by Nonselective Beta-Blockers: A Tailored Approach","volume":"25","author":"Jachs","year":"2021","journal-title":"Clin. Liver Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII\u2014Renewing consensus in portal hypertension","volume":"76","author":"Bosch","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(18)31875-0","article-title":"\u03b2 blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): A randomised, double-blind, placebo-controlled, multicentre trial","volume":"393","author":"Villanueva","year":"2019","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jhep.2010.02.023","article-title":"Cirrhotic cardiomyopathy","volume":"53","author":"Henriksen","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/MEG.0000000000002716","article-title":"Prevalence and risk factors for cirrhotic cardiomyopathy: A prospective cross-sectional study","volume":"36","author":"Xu","year":"2024","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/JIM.0000000000000106","article-title":"Age and Ethnicity in Cirrhosis","volume":"62","author":"Sajja","year":"2014","journal-title":"J. Investig. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11357-016-9938-6","article-title":"Aging increases the susceptibility of hepatic inflammation, liver fibrosis and aging in response to high-fat diet in mice","volume":"38","author":"Kim","year":"2016","journal-title":"Age"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0168-8278(99)80287-6","article-title":"Chronic liver disease in the extremely elderly of 80 years or more: Clinical characteristics, prognosis and patient survival analysis","volume":"31","author":"Hoshida","year":"1999","journal-title":"J. Hepatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/apt.12563","article-title":"Systematic review with meta-analysis: Clinical manifestations and management of autoimmune hepatitis in the elderly","volume":"39","author":"Chen","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1111\/jgh.13774","article-title":"Variations in Primary Sclerosing Cholangitis Across the Age Spectrum","volume":"32","author":"Eaton","year":"2017","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jvir.2013.03.018","article-title":"Older patient age may predict early mortality after transjugular intrahepatic portosystemic shunt creation in individuals at intermediate risk","volume":"24","author":"Parvinian","year":"2013","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"520","DOI":"10.4254\/wjh.v8.i11.520","article-title":"Predictors of mortality after transjugular portosystemic shunt","volume":"8","author":"Ascha","year":"2016","journal-title":"World J. Hepatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jhep.2018.12.009","article-title":"Age and liver transplantation","volume":"70","author":"Durand","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/TP.0000000000000090","article-title":"Combined effects of recipient age and model for end-stage liver disease score on liver transplantation outcomes","volume":"98","author":"Sharpton","year":"2014","journal-title":"Transplantation"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ","volume":"349","author":"Ojo","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/lt.22098","article-title":"Analysis of liver transplant outcomes for United Network for Organ Sharing recipients 60 years old or older identifies multiple model for end-stage liver disease-independent prognostic factors","volume":"16","author":"Aloia","year":"2010","journal-title":"Liver Transplant."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"100063","DOI":"10.1016\/j.jhepr.2019.12.001","article-title":"Beta-blockers in cirrhosis: Evidence-based indications and limitations","volume":"2","author":"Rodrigues","year":"2019","journal-title":"JHEP Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/apt.12634","article-title":"Systematic review with meta-analysis: The haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis","volume":"39","author":"Sinagra","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jhep.2017.02.005","article-title":"Carvedilol use is associated with improved survival in patients with liver cirrhosis and ascites","volume":"67","author":"Sinha","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s12072-014-9544-6","article-title":"Diastolic cardiac dysfunction is a predictor of dismal prognosis in patients with liver cirrhosis","volume":"8","author":"Karagiannakis","year":"2014","journal-title":"Hepatol. Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.amjms.2024.01.009","article-title":"Beta-blockers and cirrhosis: Striking the right balance","volume":"367","author":"Cromer","year":"2024","journal-title":"Am. J. Med. Sci."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/15\/5998\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:05:45Z","timestamp":1785758745000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/15\/5998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":33,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["jcm15155998"],"URL":"https:\/\/doi.org\/10.3390\/jcm15155998","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,1]]}}}